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Abstract 
There are a lot of natural resources that potentially used as herbal medicines in Indonesia. Some of the herbs, like Dewa leaves 
(Gynura pseudochina (L) D.C) and temu ireng rhizome (Curcuma aeruginosa Roxb.), were ussually used to increase number of 
thrombocytes in dengue patient. This current study was to determine the potential of dewa leaves (Gynura pseudochina (L) D.C) 
and temu ireng rhizome (Curcuma aeruginosa Roxb.) against the number of trombocytes, erythrocytes, and hematocrits level on 
male white rats (Rattus novergicus ) by using Heparin Induction. Dosages of the extracts were 250 mg/kg BW and 500 mg/kg 
BW used for both dewa leaves and temu ireng rhizome. Extracts were given orally to the tested animals for seven continuous 
days. The number of trombocytes, erythrocytes, and hematocrites level were examine at day 7 using sysmex XE-5000 
hematology analyzer. The result showed that the rat groups which were treated with dewa leaves extract at 500mg/kgBW; temu 
ireng Rhizomes extract at 250 mg/kgBW and 500 mg/kgBW dosages had significant differences (α = 0.05) on number of 
thrombocytes.  The percentages of thrombocytes number enhancement for temu ireng rhizomes extract 500 mg/kgBW, temu 
ireng rhizomes extract 250 mg/kgBW, dewa leaves extract 500 mg/kgBW were 26.98%, 24.48%, 19.44% respectively. The rats 
group which were treated with temu ireng Rhizomes extract at 500 mg/kgBW, dewa leaves extract at 250 mg/kgBW and 
500mg/kgBW had significant differences (α = 0.05) on erythrocytes number and hematocrits level enhancement. The percentages 
of erythrocytes number enhancement for dewa leaves extract at dose of 500 mg/kgBW and 250 mg/kgBW, temu ireng rhizomes 
extract 500 mg/kgBW were 9.59%, 9.11%, 9.02% respectively. The highest percentages of hematocrits level enhancement was 
given by dewa leaves extract at dose of 500 mg/kgBW (10,97%), suggesting that the extracts treatment would not trigger plasma 
leakage. Thus, dewa leaves extract at 500mg/kgBW; temu ireng rhizomes extract at 250 mg/kgBW and 500 mg/kgBW dosages 
are potential as candidates to be medicinal herbs to increase numbers of thrombocytes on dengue fever treatment 
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1. Introduction 
Dengue fever is an infectious disease carried by mosquitoes and caused by any of four related dengue viruses. 
The Aedes aegypti mosquito is the primary vector of dengue. The virus is transmitted to humans through the bites of 
infected female mosquitoes1. 
Dengue cases in Indonesia tend to increase due the global warming. The information center of Health Department 
has reported 77.489 dengue cases with 585people died in 2009. An estimated 50 million dengue infections occur 
annually and approximately 2.5 billion people live in dengue endemic countries. Some 1.8 billion (more than 70%) 
of the population at risk for dengue worldwide live in member states of the WHO South-East Asia Region and 
Western Pacific Region, which bear nearly 75% of the current global disease burden due to dengue. In Indonesia, 
where more than 35% of the country’s population lives in urban areas, 150 000 cases were reported in 2007 (the 
highest on record) with over 25 000 cases reported from both Jakarta and West Java. The case-fatality rate was 
approximately 1%1. Jakarta had the biggest number of dengue cases in 2008, which nearly 21% of total cases in the 
whole country. There were 28 373 cases from totally 137 469 dengue infection cases in Indonesia. The number of 
cases  reduced during January-February 2009 1,2. 
Symptoms of typical uncomplicated (classic) dengue usually start with fever within 4 to 7 days after you have 
been bitten by an infected mosquito. These symptoms include: high fever, up to 105ºF, severe headache, retro-orbital 
(behind the eye) pain,leukcopenia, thrombocytopenia, severe joint and muscle pain, nausea and vomiting, and rash. 
The rash may appear over most of the body 3 to 4 days after the fever begins, and then subsides after 1 to 2 days. 
There may be a second rash a few days later3. Thrombocytopenia is a deficiency of platelets (thrombocytes) in 
blood2 
There are no spesific treatment for dengue fever. All treatments are meant to relieve the symptoms. Recently, 
peoples tend to give herbal medicinice for dengue patients. There are several herbs that often be used for dengue 
treatment (i.e. Dewa leaves (Gynura pseudochina (L) D.C) and temu ireng rhizome (Curcuma aeruginosa Roxb.). 
Dewa leaves (Gynura pseudochina (L) D.C) have some pharmacological effect, such anti coagulant, anti pyretic, 
diuretic4. Dewa leaves contain saponin, flavonoids, tannins, steroids, triterpenoids,  chlorogenic acid, cafeic acid, 
vanillic acid, parafumaric acid, p-hydroxy benzoic acid5. 
Temu ireng (Curcuma aeruginosa Roxb.) is one of Zingiberaceae family member. It’s been known as one of 
popular traditional medicinal herb in Indonesia. Temu ireng rhizome contains saponin, flavonoids, alkaloids, 
polyphenols, curcuminoids, lipids, starch, resin and essential oils (tomerone, zingiberene). Temu ireng had been used 
to relieve damaged cells. Dengue patiens can be treated by temu ireng to repair the damages of liver cells. Peoples 
used temu ireng to relive stomache, enteritis, asthma, rheumatic, to increase appetite, to prevent obesity and 
anthelmetic6.  
This current study was to determine the potential of dewa leaves (Gynura pseudochina (L) D.C)and temu ireng 
rhizome (Curcuma aeruginosa Roxb.) against the number of trombocytes, erythrocytes, and hematocrits level on 
male white rats (Rattus novergicus) by using Heparin Induction Method.   
2. Experiments 
2.1. Material 
2.1.1.  Plant material 
The dried Dewa leaves (Gynura pseudochina (L) D.C) and temu ireng rhizome (Curcuma aeruginosa Roxb.) 
were collected from Manoko Plantation,  Lembang, Bandung, Indonesia, in the month of Februay-March, 2011. The 
plant was authenticated by the taxonomy laboratory, Department of Biology, Mathematics and Natural Sciences 
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Faculty, Padjadjaran University. 
2.1.2. Animal 
Adult Wistar rats weighting between 150-250 g were used for the in vivo evaluation. They were housed under 
standard laboratory conditions and were fed with standard animal feed and water ad libitum. The experimental 
protocol was approved by institutional animal ethical committee. 
2.2. Methods 
2.2.1. Preparation of plant extract  
The extraction of Dewa leaves (Gynura pseudochina (L) D.C) and temu ireng rhizome (Curcuma aeruginosa 
Roxb.) were carried out at room temperature. The dried plant materials were powdered in a mechanical grinder. The 
dried powdered Dewa leaves  and temu ireng rhizome then macerated in ethanol for 3 x 24 hours. The solvent was 
changed every 24 hours, and filtered through a cotton plug followed by Whatman filter paper number 1. The extract 
was then concentrated by using a rotary evaporator.  
2.2.2. Histochemical Analysis 
The present of alkaloid in callus, embriogenic and non embryogenic, was analyzed by using Jeffrey’s reagent. 
The presence of alkaloid in cell was marked as yellow-brown color. The terpenoid was detected using 0.03 % neutral 
red. The presence terpenoid in cell was marked as red color. The observation was conducted  under Nikon inverted 
microscope. 
2.2.3. Evaluation of moisture content of extract  
Sufficient wet sample (at least 25g) was weighted to yield a minimum of 5 mL water. Weight (W1) was recorded 
to nearest 1 mg, and transfered to 500 mL flask. Sufficient toluene was added to cover sample completely. 
Immediately receiving tube was filled with toluene, pouring it through top of condenser. Bring to boil and distill 
slowly, ca. 2 drops/sec, until most of the water passeses over, then increased rate of distillation to about 4 drops/sec. 
Distilled 1hr (or longer if necessary for wetter samples) to obtain clearing at the top of the condenser. When all water 
had apparently been distilled, condenser was washed down by pouring toluene in at top and continue distillation for 
a short time (approximately 15 min) to ensure all water is distilled. If 0.1 mL of additional water was distilled in 15 
minutes, repeat this step. If water remains in the condenser after distillation was completed, washed it down with 
toluene. Let receiving tube went to room temperature and volume of water in lower layer of receiver  was read and 
recorded to nearest 0.01 mL. 
2.2.4. Phytochemical screening 
The screening was performed for triterpenes/steroids, mono- and sesquiterpenes, alkaloids, quinones, flavonoids, 
saponins, tannins, and phenolic acids were carried out by Fransworth modified method7. 
2.2.5. Thin layer chromatography 
The extracts of both of Dewa leaves (Gynura pseudochina (L) D.C) and temu ireng rhizome (Curcuma 
aeruginosa Roxb.) were analyzed by thin layer chromatographic method using silica gel GF254 plates, n-hexane dan 
ethyl acetate (6 + 4) as TLC developing solvent mixture  for temu ireng rhizome extract and metilentri chloride and 
methanol (9,5 + 0,5)  as TLC developing solvent mixture  for dewa leaves extract. The spots were visualized under 
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UV   254 nm and 366 nm, and using sulfuric acid 10% in ethanol as spray reagent. 
2.2.6. Evaluation of  the extracts  activity on levels of thrombocytes, erythrocytes and hematocrits level  
Data obtained from laboratory based studies by using 24 male Wistar rats weighting between 150-250 g 
maintained at room temperature. The studies carried out in serum of animal and the platelet, erythrocytes and 
hematocrytes count were carried out in authenticated laboratories. Animals were divided  into six groups, each group 
contained four rats (Table 1).  
Tabel 1. Animal Grouping 
Group I (NC) Negative control group. Animals in this group were only administered with heparin 150 IU intraperitoneally (i.p.). 
Group II (DL-1) Animals in this group were administered with heparin 150 IU intraperitoneally (i.p.) and were given dewa leaves 
(DL) extracts orally  at doses 250  mg/kg BW, respectively 
Group III (DL-2) Animals in this group were administered with heparin 150 IU intraperitoneally (i.p.) and were given dewa leaves 
(DL) extracts orally  at doses 500  mg/kg BW, respectively 
Group IV (TIR-1) Animals in this group were administered with heparin 150 IU intraperitoneally (i.p.) and were given temu ireng 
rhizome (TIR) extracts orally at doses 250  mg/kg BW, respectively 
Group V (TIR-2) Animals in this group were administered with heparin 150 IU intraperitoneally (i.p.) and were given temu ireng 
rhizome (TIR) extracts orally at doses 500  mg/kg BW, respectively 
Group VI (PC) Normal control group. Animals in this group were not treated with any tested procedures. 
 
Each extracts were administered to the tested animals every morning for seven days. Blood samples  collected at 
days seventh from tail of all animals. 
Approx. 50–100 μl blood were collected into potassium- EDTA-coated tubes. The number of platelets, 
erythrocytes and hematocrits level were determined within 1 h after withdrawal in 10 μl samples of whole blood 
using sysmex XE-5000 hematology analyzer. The percentage of thrombocytes, erythrocytes and hematocrits level 
were determined in vehicle control and dosage groups relative to the initial value of control or dosage group, 
respectively. Calculated percent values of controls were taken as 100%. Percent inhibition of thrombocytopenia (or 
leucocytopenia) is calculated in dosage groups relative to control. 
2.2.7. Statistical analysis 
Statistical analysis was done using analysis of variance followed by Duncan’s Multiple Range Test (DMRT) 
3. Results and Discussion 
The result from extract preparation and its moisture content evaluation were tabulated in Table 2. While the result 
of phytochemical screening was tabulated in Tabel.3 
Tabel 2. Dewa Leaves (DL) and Temu Ireng Rhizome (TIR) Extracts Characteristics 
Extracts Rendemen (%) Colour Moisture contents (%) 
DL 12,79  Black 9,30  
TIR 24,13  Dark green 9,09  
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Tabel 3.Phytochemical Screening Dewa Leaves (DL) and Temu Ireng Rhizome (TIR) 
Phytochemicals groups DL TIR 
Alkaloid - + 
Polyphenol + + 
Tanin + + 
Saponin - + 
Flavonoid + + 
Monoterpene&Sesquiterpene + + 
Steroid + + 
Triterpenoid - - 
Kuinon - + 
 Notes : (- ) not detected, (+) detected 
 
Both DL and TIR content flavonoid. Based on Soegijanto, et. All (2010), flavonoid especially quercetine can 
increase number of thombocytes in blood8 
Tin layer chromatography result for dewa leaves and temu ireng rhizome were tabulated  in  Table 4 and Table 5 
Tabel 4. Thin Layer Chromatogram of Dewa Leaves (Gynura pseudochina (L) D.C) 
Spots Rf Visible UV 254 nm UV 366 nm H2SO4 in 10% ethanol 
1 0,10 yellow violet green yellow 
2 0,21 green violet light green  green 
3 0,32 - - light  green   
4 0,47 yellowish green violet light green yellow 
5 0,84 yellow violet green  yellowish green 
 
Tabel 5. Thin Layer Chromatogram of Temu Ireng Rhizome (Curcuma aeruginosa Roxb.) 
Spots Rf Visible UV 254 nm UV 366 nm H2SO4 in 10% ethanol 
1 0,12 yellow violet orange yellow 
2 0,23 green violet orange green 
3 0,41 - - orange - 
4 0,61 yellowish green violet violet Yellow 
5 0,73 yelow violet orange yellowish green 
 
The experimental data were collected at day 7 after administration of  dewa leaves (DL) and temu ireng rhizome 
extracts (TIR). The data on rats thrombocytes amount was showed at tabel 5 and the graphic was showed in Fig. 1. 
Tabel 6. Dewa Leaves (DL) and Temu Ireng Rhizome (TIR) Activity on Numbers of Thrombocytes 
Groups Thrombocytes (105/mm3) Enhancement (%) 
I 5.38  
II (DL-1) 5.56 3.35 
III (DL-2) 6.42 19.33 
IV (TIR-1) 6.71 24.72 
V (TIR-2) 6.83 26.95 




















Figure 1. Dewa leaves (DL) and temu ireng rhizome (TIR) activity on number of thrombocytes. 
Data were analyzed by one-way Anova test followed by Duncan’s Multiple Range Test (DMRT) with degree of 
significance α 0.05. The anova result showed that amount of thrombocytes from rats that were given TIR and DL 
extracts at 500 mg/kg BW and 250 mg/kg BW dossages and DL at 500 mg/kg BW dossage had anti 
thrombocytopenia activity, with percentage values 26.95%,  24.72%, 19.33% respectively. It means the extracts can 
increase the number of thrombocytes.  
The data on erythrocytes level in rats at day 7 after administration of extract was showed at tabel 6 and the 
graphic was showed at picture 2. 
Tabel 7. Dewa Leaves (DL) and Temu Ireng Rhizomes (TIR) activity on numbers of erythrocytes 
Groups Erythrocytes (106/mm3) Enhancement (%) 
I 46.03  
II (DL-1) 48.30 4.93 
III (DL-2) 51.08 12.2 
IV (TIR-1) 47.08 2.28 
V (TIR-2) 49.80 8.19 













Figure 2. Dewa leaves (DL) and temu ireng rhizome (TIR)activity on number of erythrocytes. 
 
 
140   W. Moelyono Moektiwardoyo et al. /  Procedia Chemistry  13 ( 2014 )  134 – 141 
 
The Anova result showed that amount of erythrocytes from rats that were given DL extracts at 500 mg/kg BW 
and 250 mg/kg BW dosages and TIR at 250 mg/kgBW had anti anemia activity. The average percentages of 
erythrocytes number enhancement for DL extract 500 mg/kgBW dosage and 250 mg/kg BW, TIR extract 500 
mg/kgBW were 17.24%, 11.37%, 10.27%,  respectively. 
Tabel 8. Dewa Leaves (DL) and Temu Ireng Rhizomes (TIR) Activity on Hematocrits Level 
Groups Hhematocrits level (%) Enhancement (%) 
I 46.03   
II (DL-1) 48.30 4.93 
III (DL-2) 51.08 12.2 
IV (TIR-1) 47.08 2.28 
V (TIR-2) 49.80 8.19 
















Figure 3. Dewa leaves (DL) and temu ireng rhizome (TIR) activity on hematocrits level. 
 
The highest percentages of hematocrits level enhancement was given by dewa leaves extract at dose of 500 
mg/kgBW (10,97%). However the increase is still below 20%, suggesting that the extracts treatment will not trigger 
plasma leakage. 
4. Conclusion 
Temu ireng rhizome at 500 mg/kg BW and 250 mg/kg BW dosages and dewa leaves  at dosages 250 mg/kgBW 
shows anti thrombocytopenia and anti anemia activities. Temu ireng rhizome extract gives better anti 
thrombocytopenia activity than dewa leaves extract, therefore it’s  potential to be developed as medicinal herb for 
revealing dengue symptoms 
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